BELITE BIO INC - ADR (BLTE) Top Institutional Shareholders
BELITE BIO INC - ADR (BLTE) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $1.36B in BLTE holdings during the latest filing period.
Darwin Global Management, Ltd. is currently the largest disclosed institutional shareholder of BLTE tracked by InsiderSet, reporting ownership valued at approximately $456.10M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $453.54M, representing an estimated loss of -0.56% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 88% of the total disclosed BLTE value among the investors covered in this analysis. Major shareholders include Darwin Global Management, Ltd., Paradigm Biocapital Advisors Lp, Ubs Group Ag, and several other long-term asset managers with concentrated positions in BELITE BIO INC - ADR (BLTE).
This page ranks the largest institutional BLTE shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
74
Total Reported Value
$1.36B
Largest Holder
Darwin Global Management, Ltd.
Largest Position
$456.10M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
96
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Darwin Global Management, Ltd. | 12.10% | 3,057,412 | $456,104,722 | $453,536,496 | -$2,568,226 | -0.56% | |
| Paradigm Biocapital Advisors Lp | 3.63% | 1,114,784 | $177,741,161 | $165,367,059 | -$12,374,102 | -6.96% | |
| Ubs Group Ag | 0.02% | 768,359 | $122,507,159 | $113,978,374 | -$8,528,785 | -6.96% | |
| Rtw Investments, Lp | 1.13% | 715,332 | $114,052,534 | $106,112,349 | -$7,940,185 | -6.96% | |
| Millennium Management Llc | 0.07% | 570,088 | $90,894,831 | $84,566,854 | -$6,327,977 | -6.96% | |
| Holocene Advisors, Lp | 0.19% | 494,495 | $78,842,283 | $73,353,388 | -$5,488,895 | -6.96% | |
| Eventide Asset Management, Llc | 0.94% | 357,650 | $57,023,716 | $53,053,801 | -$3,969,915 | -6.96% | |
| Deerfield Management Company, L.P. | 0.57% | 304,013 | $48,471,833 | $45,097,288 | -$3,374,545 | -6.96% | |
| Morgan Stanley | 0.00% | 201,409 | $32,112,649 | $29,877,011 | -$2,235,638 | -6.96% | |
| Perceptive Advisors Llc | 0.48% | 151,979 | $24,231,532 | $22,544,565 | -$1,686,967 | -6.96% | |
| Patient Square Capital Lp | 3.30% | 116,684 | $18,604,097 | $17,308,905 | -$1,295,192 | -6.96% | |
| Goldman Sachs Group Inc | 0.00% | 105,509 | $16,822,355 | $15,651,205 | -$1,171,150 | -6.96% | |
| Mpm Bioimpact Llc | 1.08% | 88,045 | $14,037,895 | $13,060,595 | -$977,300 | -6.96% | |
| Affinity Asset Advisors, Llc | 0.61% | 65,000 | $10,363,600 | $9,642,100 | -$721,500 | -6.96% | |
| Fred Alger Management, Llc | 0.04% | 62,574 | $9,976,799 | $9,282,227 | -$694,572 | -6.96% | |
| Pfm Health Sciences, Lp | 1.00% | 59,432 | $9,475,838 | $8,816,143 | -$659,695 | -6.96% | |
| Renaissance Technologies LLC | Jim Simons | 0.01% | 52,000 | $8,290,880 | $7,713,680 | -$577,200 | -6.96% |
| Longaeva Partners L.P. | 0.26% | 33,492 | $5,339,964 | $4,968,203 | -$371,761 | -6.96% | |
| Td Asset Management Inc | 0.00% | 33,410 | $5,326,890 | $4,956,039 | -$370,851 | -6.96% | |
| Bnp Paribas Financial Markets | 0.00% | 32,525 | $5,185,786 | $4,824,759 | -$361,028 | -6.96% | |
| Adar1 Capital Management, Llc | 0.26% | 26,880 | $4,285,747 | $3,987,379 | -$298,368 | -6.96% | |
| Artia Global Partners Lp | 0.90% | 24,989 | $3,984,246 | $3,706,868 | -$277,378 | -6.96% | |
| Quadrature Capital Ltd | 0.04% | 23,708 | $3,780,004 | $3,516,845 | -$263,159 | -6.96% | |
| Aquatic Capital Management Llc | 0.09% | 20,294 | $3,235,675 | $3,010,412 | -$225,263 | -6.96% | |
| Manufacturers Life Insurance Company, The | 0.00% | 19,600 | $3,125,024 | $2,907,464 | -$217,560 | -6.96% | |
| Squarepoint Ops Llc | 0.01% | 16,981 | $2,707,451 | $2,518,962 | -$188,489 | -6.96% | |
| State Street Corp | 0.00% | 16,048 | $2,558,693 | $2,380,560 | -$178,133 | -6.96% | |
| Bank Of Montreal | 0.00% | 15,981 | $2,548,011 | $2,370,622 | -$177,389 | -6.96% | |
| Trexquant Investment Lp | 0.02% | 15,072 | $2,403,080 | $2,235,780 | -$167,300 | -6.96% | |
| Xtx Topco Ltd | 0.04% | 15,058 | $2,400,848 | $2,233,704 | -$167,144 | -6.96% | |
| Balance Capital Partners L.P. | 2.63% | 14,500 | $2,311,880 | $2,150,930 | -$160,950 | -6.96% | |
| Verdad Advisers, Lp | 2.48% | 13,813 | $2,202,345 | $2,049,020 | -$153,325 | -6.96% | |
| Eversource Wealth Advisors, Llc | 0.06% | 43,249 | $2,092,240 | $6,415,557 | +$4,323,317 | +206.64% | |
| Jane Street Group, Llc | 0.00% | 12,222 | $1,948,676 | $1,813,011 | -$135,665 | -6.96% | |
| Blackstone Inc. | 0.01% | 10,692 | $1,704,732 | $1,586,051 | -$118,681 | -6.96% | |
| Geode Capital Management, Llc | 0.00% | 10,427 | $1,662,480 | $1,546,741 | -$115,739 | -6.96% | |
| Highvista Strategies Llc | 0.35% | 8,033 | $1,280,781 | $1,191,615 | -$89,166 | -6.96% | |
| Voleon Capital Management Lp | 0.03% | 7,883 | $1,256,866 | $1,169,364 | -$87,502 | -6.96% | |
| Barclays Plc | 0.00% | 6,822 | $1,087,700 | $1,011,975 | -$75,725 | -6.96% | |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | 1.39% | 6,004 | $957,278 | $890,633 | -$66,645 | -6.96% | |
| Amundi | 0.00% | 4,210 | $671,242 | $624,511 | -$46,731 | -6.96% | |
| Smartharvest Portfolios, Llc | 0.28% | 4,187 | $667,575 | $621,100 | -$46,475 | -6.96% | |
| Bank Of America Corp | 0.00% | 3,778 | $602,365 | $560,429 | -$41,936 | -6.96% | |
| High Net Worth Advisory Group Llc | 0.13% | 3,500 | $558,040 | $519,190 | -$38,850 | -6.96% | |
| Convergence Financial, Llc | 0.07% | 2,968 | $473,222 | $440,273 | -$32,949 | -6.96% | |
| Ameriprise Financial Inc | 0.00% | 2,767 | $441,170 | $410,457 | -$30,713 | -6.96% | |
| Engineers Gate Manager Lp | 0.00% | 2,489 | $396,846 | $369,218 | -$27,628 | -6.96% | |
| Axq Capital, Lp | 0.05% | 2,372 | $378,192 | $351,862 | -$26,330 | -6.96% | |
| Royal Bank Of Canada | 0.00% | 2,257 | $360,000 | $334,803 | -$25,197 | -7.00% | |
| Citadel Advisors Llc | 0.00% | 2,008 | $320,156 | $297,867 | -$22,289 | -6.96% |
Frequently asked questions about BLTE
Who owns the most BLTE stock?
The largest holders of BLTE are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for BELITE BIO INC - ADR (BLTE).
Is BLTE widely held by superinvestors?
Many widely followed stocks like BLTE appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly BLTE is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.